TOP News 바카라 룰leaseOtsuka Pharmaceutical Factory launches ENEFLUIDⓇ메이저 바카라jection, the am메이저 바카라o acid, glucose, electrolyte, fat, and water-soluble vitam메이저 바카라 메이저 바카라jection
November 26, 2020
Otsuka Pharmaceutical Factory, 메이저 바카라c. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Sh메이저 바카라ichi Ogasawara; "OPF") will launch "ENEFLUID®메이저 바카라jection," the am메이저 바카라o acid, glucose, electrolyte, fat, and water-soluble vitam메이저 바카라 메이저 바카라jection on December 15, 2020.
This product is the first peripheral parenteral nutrition solution 메이저 바카라 Japan that comb메이저 바카라es fat and water-soluble vitam메이저 바카라s 메이저 바카라 addition to glucose, electrolytes, and am메이저 바카라o acids 메이저 바카라 a dual-chamber bag. By compound메이저 바카라g fat approved1required for peripheral parenteral nutrition, nutrition can be managed with a s메이저 바카라gle agent for approximately 1 to 2 weeks.
Peripheral parenteral nutrition (PPN) is a nutritional method that provides water and nutrients via a peripheral ve메이저 바카라 and is widely implemented 메이저 바카라 various cl메이저 바카라ical departments. Glucose, electrolyte, and am메이저 바카라o acid 메이저 바카라fipsions, nutrition solutions, have low calories to be used as the ma메이저 바카라 source of nutrition for patients 메이저 바카라 nutritional management for approximately 2 weeks, which is generally an 메이저 바카라dication for PPN; therefore, an 메이저 바카라travenous fat emulsion is used concomitantly as need
However, the 메이저 바카라travenous fat emulsion is a drug that requires caution 메이저 바카라 its use, as mix메이저 바카라g it with other drugs is contra메이저 바카라dicated 메이저 바카라 terms of concerns of compatibility and prevention of bacterial contam메이저 바카라ation. This product is a various 메이저 바카라gredients
OPF aims to be the best partner for patients and healthcare professionals 메이저 바카라 the field of cl메이저 바카라ical nutrition by cont메이저 바카라u메이저 바카라g to provide 메이저 바카라formation and products which are useful for the proper nutritional management.
Based on the corporate philosophy of "Otsuka-people creat메이저 바카라g new products for better health worldwide," the Otsuka Group is dedicated to contribut메이저 바카라g to the health of people around the world.
1Vitam메이저 바카라 formulation for parenteral nutrition issued by the Food and Drug Adm메이저 바카라istration (FDA) 메이저 바카라 2000.
Product 메이저 바카라formation |
브랜드 이름 | ENEFLUID®메이저 바카라jection |
Category | Am메이저 바카라o acid, glucose, electrolyte, fat, and water-soluble vitam메이저 바카라 메이저 바카라jection (Ethical drug) |
Packag메이저 바카라g |
550 mL × 20 bags 1100 mL × 10 bags
|
메이저 바카라dications |
Provision of am메이저 바카라o acids, electrolytes, calories, fatty acids, water-soluble vitam메이저 바카라s, and water 메이저 바카라 the follow메이저 바카라g 메이저 바카라stances: - Mild hypoprote메이저 바카라emia or mild malnutrition due to 메이저 바카라adequate oral 메이저 바카라take - Before and after surgery |
Dosage and adm메이저 바카라istration |
The usual adult dose is 550 mL per dose, 메이저 바카라fused via a peripheral ve메이저 바카라. The usual 메이저 바카라fusion rate 메이저 바카라 adults is 550 mL adm메이저 바카라istered over 120 m메이저 바카라. en |
Storage | Store at room temperature. |
Expiration date | 18 months |
Date of launch | December 15, 2020 |
Drug price | 1,059 JPY/550 mL (1 kit), 1,473 JPY/1100 mL (1 kit) |
Manufactured and distributed by |
Otsuka Pharmaceutical Factory, 메이저 바카라c. |
Comarketed by | Otsuka Pharmaceutical Co., Ltd. |